• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94703ZQ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cellulitis (1768); Rash (2033); Skin Irritation (2076)
Event Date 09/12/2018
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: with lidocaine.(b)(4).Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The events of swelling, puffiness, redness, discomfort, hard, lump, cellulitis and mild rash are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.A review of the device history record has been initiated and analysis of the data has not been completed.Device labeling: precautions for use: as a matter of general principle, injection of a medical device is associated with a risk of infection.Standard precautions associated with injectable materials shall be followed.Undesirable effects the patients must be informed that there are potential side effects associated with implantation of this product, which may occur immediately or may be delayed.These include, but are not limited to: inflammatory reactions (redness, oedema, erythema, etc.) which may be associated with itching and/or pain on pressure and/or paresthesia, occurring after the injection.These reactions may last for a week.Induration or nodules at the injection site.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm voluma with lidocaine in the chin line/depression, juvéderm volift with lidocaine in the marionette lines and juvéderm volbella with lidocaine in the upper and lower lips.About 2 months later, the patient had a dental cleaning.Then about 1 month after that the patient was injected with botox.There were no concerns and all good as usual.Around 2 months later, the patient developed hard swollen redness in the chin and lower lip areas.There was some discomfort but no fever.Patient was reviewed by the healthcare professional and prescribed the patient with keflex and prednisone.Patient returned to the clinic 9 days later and they still had hard, swollen and lump interior lip with slight redness.There was no fever or pain.Patient was prescribed ciprofloxacin and metronidazole.Keflex was stopped.It was cellulitis that was suspected 5 months after the injection.Symptoms improved after the 3rd round of antibiotics, but the patient still has a mild rash and swelling/puffiness localized on the chin line.This is the same event and the same patient reported under mdr id #3005113652-2018-01313 ((b)(4)) and mdr id #3005113652-2018-01315 ((b)(4)).This mdr is being submitted for the second suspect product, juvéderm volift with lidocaine, also a device manufactured by allergan.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLIFT WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key7978947
MDR Text Key124137681
Report Number3005113652-2018-01314
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Catalogue Number94703ZQ
Device Lot NumberV17LA70553
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/21/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/18/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
JUVEDERM VOLUMA WITH LIDOCAINE, JUVEDERM VOLBELLA
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-